

Fundamental dimension Equity attribute | AVTPeer $88.08▼-0.63% Cap $7.24BP/E 21.6x QuantScore47/100 | ARWPeer $209.76▲+0.17% Cap $10.68BP/E 13.3x QuantScore51/100 | CLMBLeader $32.84▲+2.79% Cap $612.8MP/E 29.2x QuantScore75/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
45/100 |
43/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 89/100 | 78/100 |
Health Piotroski, Altman Z, leverage & liquidity | 43/100 | 49/100 | 67/100 |
Growth Revenue / earnings growth & margins | 50/100 | 45/100 | 56/100 |
Sentiment Analyst ratings, targets & revisions | 29/100 | 31/100 | 100/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 21.6x | 13.3x | 29.2x |
Forward P/E (next FY) | 7.6x | 9.6x | 23.4x |
EV / EBITDA (TTM) | 12.4x | 10.1x | 15.4x |
Price / Sales | 0.3x | 0.3x | 0.9x |
Price / Free Cash Flow | -20.4x | 11.9x | 14.9x |
PEG ratio | 0.46 | 0.17 | -4.42 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 7 / 9 | 7 / 9 |
Altman Z-Score | 3.14 (Safe) | 1.69 (Distress) | 3.22 (Safe) |
Total debt / equity | 0.69 | 0.31 | 0.02 |
Quick ratio | 1.0x | 1.0x | 1.1x |
Interest coverage | 3.4x | 10.2x | 418.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +24.5% | +10.5% | +40.1% |
Net income growth YoY | +39.2% | +45.7% | +14.6% |
Gross margin (TTM) | 10.4% | 11.2% | 15.8% |
Operating margin (FY) | 3.1% | 3.0% | 4.5% |
FCF margin (FY) | -1.3% | -0.1% | 2.2% |
5. Trailing price performancePrice change over period |
1M return | -12.7% | -7.7% | +5.4% |
3M return | -1.5% | -1.2% | +29.0% |
6M return | +12.0% | +12.2% | +55.4% |
Year to date | +83.2% | +90.4% | +27.8% |
1Y return | +71.1% | +74.8% | -0.4% |
3Y return | +90.3% | +87.1% | +194.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $44.86 -49.1% premium | $205.10 -2.2% premium | $37.53 +14.3% upside |
Wall Street consensus target | $92.33 +4.8% · range $72.00–$110.00 | $225.00 +7.3% · range $175.00–$250.00 | — — |
Consensus stance | 35% Buy45% Hold20% Sell | 35% Buy53% Hold12% Sell | 100% Buy0% Hold0% Sell |